Ann: PainChek appoints head of Business Development for US market, page-9

  1. 342 Posts.
    lightbulb Created with Sketch. 268
    This could fly. They’re launching a potentially highly lucrative B2C product (fast deployment, higher margin) at the same time as securing US FDA, which helps B2B and B2C products - globally, given the credentials of FDA.

    It is a great way to get fast, signficant momentum (exposure, media, revenue, share price). Which all feed on each other.

    A very exciting number of weeks ahead.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.4¢
Change
-0.001(2.86%)
Mkt cap ! $62.62M
Open High Low Value Volume
3.5¢ 3.5¢ 3.4¢ $84.27K 2.479M

Buyers (Bids)

No. Vol. Price($)
2 198752 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 41500 1
View Market Depth
Last trade - 16.10pm 25/06/2025 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.